These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 17605032)

  • 1. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers.
    Olsen GW; Zobel LR
    Int Arch Occup Environ Health; 2007 Nov; 81(2):231-46. PubMed ID: 17605032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers.
    Olsen GW; Burris JM; Burlew MM; Mandel JH
    Drug Chem Toxicol; 2000 Nov; 23(4):603-20. PubMed ID: 11071397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal assessment of lipid and hepatic clinical parameters in workers involved with the demolition of perfluoroalkyl manufacturing facilities.
    Olsen GW; Ehresman DJ; Buehrer BD; Gibson BA; Butenhoff JL; Zobel LR
    J Occup Environ Med; 2012 Aug; 54(8):974-83. PubMed ID: 22842914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP Mice.
    Pouwer MG; Pieterman EJ; Chang SC; Olsen GW; Caspers MPM; Verschuren L; Jukema JW; Princen HMG
    Toxicol Sci; 2019 Apr; 168(2):519-534. PubMed ID: 30657992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of perfluorooctanoic acid with HDL cholesterol and circulating miR-26b and miR-199-3p in workers of a fluorochemical plant and nearby residents.
    Wang J; Zhang Y; Zhang W; Jin Y; Dai J
    Environ Sci Technol; 2012 Sep; 46(17):9274-81. PubMed ID: 22862179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate.
    Sakr CJ; Leonard RC; Kreckmann KH; Slade MD; Cullen MR
    J Occup Environ Med; 2007 Aug; 49(8):872-9. PubMed ID: 17693785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project.
    Frisbee SJ; Shankar A; Knox SS; Steenland K; Savitz DA; Fletcher T; Ducatman AM
    Arch Pediatr Adolesc Med; 2010 Sep; 164(9):860-9. PubMed ID: 20819969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum perfluorooctanoic acid and hepatic enzymes, lipoproteins, and cholesterol: a study of occupationally exposed men.
    Gilliland FD; Mandel JS
    Am J Ind Med; 1996 May; 29(5):560-8. PubMed ID: 8732932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations.
    Olsen GW; Burris JM; Burlew MM; Mandel JH
    J Occup Environ Med; 2003 Mar; 45(3):260-70. PubMed ID: 12661183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An occupational exposure assessment of a perfluorooctanesulfonyl fluoride production site: biomonitoring.
    Olsen GW; Logan PW; Hansen KJ; Simpson CA; Burris JM; Burlew MM; Vorarath PP; Venkateswarlu P; Schumpert JC; Mandel JH
    AIHA J (Fairfax, Va); 2003; 64(5):651-9. PubMed ID: 14521435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant.
    Steenland K; Tinker S; Frisbee S; Ducatman A; Vaccarino V
    Am J Epidemiol; 2009 Nov; 170(10):1268-78. PubMed ID: 19846564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of hepatic peroxisome proliferation by 8-2 telomer alcohol feeding in mice: formation of perfluorooctanoic acid in the liver.
    Kudo N; Iwase Y; Okayachi H; Yamakawa Y; Kawashima Y
    Toxicol Sci; 2005 Aug; 86(2):231-8. PubMed ID: 15888668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do perfluoroalkyl substances affect metabolic function and plasma lipids?--Analysis of the 2007-2009, Canadian Health Measures Survey (CHMS) Cycle 1.
    Fisher M; Arbuckle TE; Wade M; Haines DA
    Environ Res; 2013 Feb; 121():95-103. PubMed ID: 23266098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeled Perfluorooctanoic Acid (PFOA) Exposure and Liver Function in a Mid-Ohio Valley Community.
    Darrow LA; Groth AC; Winquist A; Shin HM; Bartell SM; Steenland K
    Environ Health Perspect; 2016 Aug; 124(8):1227-33. PubMed ID: 26978841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers.
    Sakr CJ; Kreckmann KH; Green JW; Gillies PJ; Reynolds JL; Leonard RC
    J Occup Environ Med; 2007 Oct; 49(10):1086-96. PubMed ID: 18000414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid.
    Olsen GW; Gilliland FD; Burlew MM; Burris JM; Mandel JS; Mandel JH
    J Occup Environ Med; 1998 Jul; 40(7):614-22. PubMed ID: 9675720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reductions in serum lipids with a 4-year decline in serum perfluorooctanoic acid and perfluorooctanesulfonic acid.
    Fitz-Simon N; Fletcher T; Luster MI; Steenland K; Calafat AM; Kato K; Armstrong B
    Epidemiology; 2013 Jul; 24(4):569-76. PubMed ID: 23685825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early life perfluorooctanoic acid (PFOA) exposure and overweight and obesity risk in adulthood in a community with elevated exposure.
    Barry V; Darrow LA; Klein M; Winquist A; Steenland K
    Environ Res; 2014 Jul; 132():62-9. PubMed ID: 24742729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining confounding by diet in the association between perfluoroalkyl acids and serum cholesterol in pregnancy.
    Skuladottir M; Ramel A; Rytter D; Haug LS; Sabaredzovic A; Bech BH; Henriksen TB; Olsen SF; Halldorsson TI
    Environ Res; 2015 Nov; 143(Pt A):33-8. PubMed ID: 26432473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts.
    Winquist A; Steenland K
    Epidemiology; 2014 Mar; 25(2):255-64. PubMed ID: 24407430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.